Prediction of in vivo drug clearance from in vitro data. II: Potential inter-ethnic differences

作者: S. Inoue , E. M. Howgate , K. Rowland-Yeo , T. Shimada , H. Yamazaki

DOI: 10.1080/00498250600683262

关键词: MedicinePharmacologyOmeprazoleTolbutamidePopulationChlorzoxazoneTriazolamADMEPharmacokineticsAlprazolam

摘要: Potential differences in drug clearance between Japanese and Caucasians were investigated by integrating data on demography, liver size, the abundance of major cytochromes P450 vitro metabolic parameters. Eleven drugs (alprazolam, caffeine, chlorzoxazone, cyclosporine, midazolam, omeprazole, sildenafil, tolbutamide, triazolam, S-warfarin zolpidem) fulfilled entry criteria study (i.e. necessary metabolism available values had been reported both Japanese). Values relevant biological variables obtained from literature, predictions made using Simcyp Population-Based ADME Simulator. The ratios observed oral (CLp.o.) compared with ranged 0.6 to 2.8 (integrating 82 sources). CLp.o. for alprazolam, caffeine zolpidem not statistically different Caucasian (p>0.05), whereas those chorzoxazone, tolbutamide triazolam higher (p<0.05), sildenafil (p<0.05). values, predicted data, within 3-fold vivo seven 11 Japanese. 1.6 4.9. significantly triazolam. Only partial success predicting ethnic indicates need larger more reliable databases variables. With such information, silico might be used confidence decrease repeating pharmacokinetic studies groups.

参考文章(60)
Susumu Imaoka, Takao Yamada, Toyoko Hiroi, Koji Hayashi, Toshiyuki Sakaki, Yoshiyasu Yabusaki, Yoshihiko Funae, Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochemical Pharmacology. ,vol. 51, pp. 1041- 1050 ,(1996) , 10.1016/0006-2952(96)00052-4
Thomas Lang, Kathrin Klein, Joachim Fischer, Andreas Nussler, Peter Neuhaus, Ute Hofmann, Michel Eichelbaum, Matthias Schwab, Ulrich Zanger, Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics. ,vol. 11, pp. 399- 415 ,(2001) , 10.1097/00008571-200107000-00004
H. Yasuhara, E. Uchida, M. S. M. Pieters, S. J. de Visser, J. M. A. van Gerven, N. Uchida, A. F. Cohen, J. M. Kroon, L. V. Nanhekhan, B. Altorf, A. J. Meinders, K. Yasuda, R. C. Schoemaker, Pharmacodynamics and pharmacokinetics of a single oral dose of nitrazepam in healthy volunteers: an interethnic comparative study between Japanese and European volunteers. The Journal of Clinical Pharmacology. ,vol. 38, pp. 1129- 1136 ,(1998) , 10.1177/009127009803801207
Masahiro Hiratsuka, Yoh Takekuma, Naomi Endo, Kaori Narahara, Samar Hamdy, Yukinaga Kishikawa, Masaki Matsuura, Yasuyuki Agatsuma, Tomoko Inoue, Michinao Mizugaki, Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population European Journal of Clinical Pharmacology. ,vol. 58, pp. 417- 421 ,(2002) , 10.1007/S00228-002-0499-5
K Nakamura, F Goto, W A Ray, C B McAllister, E Jacqz, G R Wilkinson, R A Branch, Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations Clinical Pharmacology and Therapeutics. ,vol. 38, pp. 402- 408 ,(1985) , 10.1038/CLPT.1985.194
I. Johansson, E. Lundqvist, L. Bertilsson, M. L. Dahl, F. Sjoqvist, M. Ingelman-Sundberg, Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 11825- 11829 ,(1993) , 10.1073/PNAS.90.24.11825
Tomonori Tateishi, Hironori Nakura, Masako Asoh, Minoru Watanabe, Masami Tanaka, Toshio Kumai, Sachio Takashima, Susumu Imaoka, Yoshihiko Funae, Yoshiyasu Yabusaki, Tetsuya Kamataki, Shinichi Kobayashi, A COMPARISON OF HEPATIC CYTOCHROME P450 PROTEIN EXPRESSION BETWEEN INFANCY AND POSTINFANCY Life Sciences. ,vol. 61, pp. 2567- 2574 ,(1997) , 10.1016/S0024-3205(97)01011-4
Yuko Nishida, Tsuyoshi Fukuda, Isamu Yamamoto, Junichi Azuma, CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10. Pharmacogenetics. ,vol. 10, pp. 567- 570 ,(2000) , 10.1097/00008571-200008000-00010
Harumi Takahashi, Teruki Sato, Yoshiaki Shimoyama, Noriko Shioda, Teppei Shimizu, Suzuko Kubo, Noboru Tamura, Hitoshi Tainaka, Toshio Yasumori, Hirotoshi Echizen, None, Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone Clinical Pharmacology & Therapeutics. ,vol. 66, pp. 569- 581 ,(1999) , 10.1053/CP.1999.V66.103378001
W. Mück, S. Unger, K. Kawano, G. Ahr, Inter‐ethnic comparisons of the pharmacokinetics of the HMG‐CoA reductase inhibitor cerivastatin British Journal of Clinical Pharmacology. ,vol. 45, pp. 583- 590 ,(1998) , 10.1046/J.1365-2125.1998.00717.X